ArticleMedical oncology (Northwood, London, England)2017

Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin.

Hiroaki Soyama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.